SEER

Seer (SEER)

Seer Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SEER

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/08/17	05 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SEER	Seer Inc
2024/08/15	05 : 05	GlobeNewswire Inc.	Seer Appoints Nicolas Roelofs to its Board of Directors	NASDAQ:SEER	Seer Inc
2024/08/09	20 : 00	GlobeNewswire Inc.	Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference	NASDAQ:SEER	Seer Inc
2024/08/09	05 : 29	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SEER	Seer Inc
2024/08/09	05 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SEER	Seer Inc
2024/08/09	05 : 05	GlobeNewswire Inc.	Seer Reports Second Quarter 2024 Financial Results	NASDAQ:SEER	Seer Inc
2024/08/03	07 : 33	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:SEER	Seer Inc
2024/07/20	05 : 22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SEER	Seer Inc
2024/07/19	05 : 03	GlobeNewswire Inc.	Seer to Report Second Quarter 2024 Financial Results on August 8, 2024	NASDAQ:SEER	Seer Inc
2024/07/13	05 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SEER	Seer Inc
2024/06/15	05 : 34	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SEER	Seer Inc
2024/06/15	05 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SEER	Seer Inc
2024/06/12	00 : 11	GlobeNewswire Inc.	Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery	NASDAQ:SEER	Seer Inc
2024/06/02	23 : 55	GlobeNewswire Inc.	Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study	NASDAQ:SEER	Seer Inc
2024/05/09	05 : 35	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SEER	Seer Inc
2024/05/09	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SEER	Seer Inc
2024/05/09	05 : 05	GlobeNewswire Inc.	Seer Reports First Quarter 2024 Financial Results	NASDAQ:SEER	Seer Inc
2024/05/09	05 : 03	GlobeNewswire Inc.	Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions	NASDAQ:SEER	Seer Inc
2024/04/24	05 : 05	GlobeNewswire Inc.	Seer to Report First Quarter 2024 Financial Results on May 8, 2024	NASDAQ:SEER	Seer Inc
2024/03/07	06 : 14	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:SEER	Seer Inc
2024/03/01	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SEER	Seer Inc
2024/03/01	06 : 05	GlobeNewswire Inc.	Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook	NASDAQ:SEER	Seer Inc
2024/02/24	07 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SEER	Seer Inc
2024/02/22	06 : 05	GlobeNewswire Inc.	Seer to Participate in the TD Cowen 44th Annual Health Care Conference	NASDAQ:SEER	Seer Inc
2024/02/08	11 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SEER	Seer Inc
2024/02/06	22 : 00	GlobeNewswire Inc.	Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery	NASDAQ:SEER	Seer Inc
2024/02/02	06 : 05	GlobeNewswire Inc.	Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024	NASDAQ:SEER	Seer Inc
2024/01/03	22 : 52	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:SEER	Seer Inc
2023/12/23	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SEER	Seer Inc
2023/12/22	06 : 05	GlobeNewswire Inc.	Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference	NASDAQ:SEER	Seer Inc